In the TME, IL6 is required to promote angiogenesis, the formation of new blood vessels from existing ones, which is critical for tumor survival, providing essential pathways for a continuous supply of nutrients and the removal of waste products to sustain their rapid growth and survival. Here, IL6 is linked to neoplasm.